? PROJECT 1 The study of retroviruses has resulted in important discoveries and led to insights into basic cell biology including mechanisms of cell signaling, regulation of gene expression, and ultimately cellular transformation and cancer. Our collaborative work within this PPG focuses on HTLV-1, which is associated primarily with adult T-cell leukemia (ATL) and neurological disease (HAM/TSP) in a small percentage of infected individuals. Disease progression by HTLV-1 has been attributed to Tax, although we and others have hypothesized and provide data that another viral gene, termed Hbz, plays a critical role in the malignant process. Our presented data, as well as the work of others, indicate that hbz is multi-functional, playing important roles in both the RNA and protein form throughout infection and establishment of latency. We have extended our proposed work through PPG collaborations to better understand the manner in which hbz promotes proliferative and survival activity in cells. Proteomic analyses identified a panel of cellular proteins that distinctly interact with hbz RNA and HBZ protein. Functional characterization of these interactions are the next critical steps and the basis for this highly integrative continuation project designed to further define the role of hbz in transformation and disease. Our overall hypothesis is that uncovering the mechanism of actions of hbz RNA and HBZ protein will provide important insight into HTLV-1 cellular transformation and disease and ultimately will provide means for therapeutic targeting to eradicate HTLV-1 persistence in the host. This highly integrated proposal as referenced by Project and Core collaborations below has two Specific Aims.
Aim 1 will dissect the mechanism(s) of action of hbz RNA and determine its contributions to the pathogenic process. We hypothesize that cellular protein interaction with hbz mRNA 2o structure translates to cell signaling pathways important for viral persistence and cellular proliferation. Our new proteomics data has identified, and we further validated, distinct cellular proteins that bind hbz mRNA.
This aim will utilize in vitro approaches (Projects 2 and 3, Cores Admin/Biostats and Viral Vector) to identify the hbz RNA interactive region and determine the functional role of cellular binding proteins in cell proliferation. We will use in vivo approaches (Animal Core) to understand the contribution of the RNA and interactive proteins in the establishment of persistence and tumor formation.
Aim 2 will dissect the mechanism(s) of action of HBZ protein and determine its contributions to HTLV-1 pathobiology. Our new proteomics data has identified, and we further validated, distinct cellular proteins that bind HBZ. In vitro approaches (Project 3, Cores Admin/Biostats and Viral Vector) including protein interaction mapping, cellular proliferation assays, and cellular transformation assays will be utilized to identify the HBZ interactive region and the functional role of key cellular binding proteins in HTLV-1 pathobiology. In vivo approaches (Animal Core, Project 2) will be used to determine the contribution of these HBZ interactive proteins in the establishment of persistence, infected cell survival, and tumor formation.

Public Health Relevance

? PROJECT 1 Approximately 15-25 million people worldwide are infected with HTLV-1 with a small percentage developing adult T-cell leukemia. The cancer is aggressive and there is currently no effective treatment. This project focuses on a novel viral gene encoded by the antisense strand of the HTLV-1 genome, termed hbz, and the proposed studies will provide a significant advance in our basic knowledge of the role of hbz in transformation and disease and will have significant implications for therapeutic targeting.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA100730-16A1
Application #
10023351
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2003-04-21
Project End
2025-05-31
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
16
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Ohio State University
Department
Type
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Murali, Bhavna; Ren, Qihao; Luo, Xianmin et al. (2018) Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss. Cancer Res 78:5618-5630
Huey, Devra D; Niewiesk, Stefan (2018) Production of Humanized Mice through Stem Cell Transfer. Curr Protoc Mouse Biol 8:17-27
Romeo, Megan; Hutchison, Tetiana; Malu, Aditi et al. (2018) The human T-cell leukemia virus type-1 p30II protein activates p53 and induces the TIGAR and suppresses oncogene-induced oxidative stress during viral carcinogenesis. Virology 518:103-115
Cherian, Mathew A; Olson, Sydney; Sundaramoorthi, Hemalatha et al. (2018) An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia. J Biol Chem 293:6844-6858
Huey, Devra D; Bolon, Brad; La Perle, Krista M D et al. (2018) Role of Wild-type and Recombinant Human T-cell Leukemia Viruses in Lymphoproliferative Disease in Humanized NSG Mice. Comp Med 68:4-14
Pérès, Eléonore; Blin, Juliana; Ricci, Emiliano P et al. (2018) PDZ domain-binding motif of Tax sustains T-cell proliferation in HTLV-1-infected humanized mice. PLoS Pathog 14:e1006933
Panfil, Amanda R; Al-Saleem, Jacob; Howard, Cory M et al. (2018) Stability of the HTLV-1 Antisense-Derived Protein, HBZ, Is Regulated by the E3 Ubiquitin-Protein Ligase, UBR5. Front Microbiol 9:80
Kenney, Adam D; Dowdle, James A; Bozzacco, Leonia et al. (2017) Human Genetic Determinants of Viral Diseases. Annu Rev Genet 51:241-263
Webb, Lindsay M; Amici, Stephanie A; Jablonski, Kyle A et al. (2017) PRMT5-Selective Inhibitors Suppress Inflammatory T Cell Responses and Experimental Autoimmune Encephalomyelitis. J Immunol 198:1439-1451
Singh, Gatikrushna; Fritz, Sarah M; Ranji, Arnaz et al. (2017) Isolation of Cognate RNA-protein Complexes from Cells Using Oligonucleotide-directed Elution. J Vis Exp :

Showing the most recent 10 out of 162 publications